mda-mb-468 glutathione content Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics | Cancer Cell International Natural product preferentially targets redox
Natural product preferentially targets redox and metabolic adaptations and aberrantly active STAT3 to inhibit breast tumor growth in vivo Cell Death & Disease Frontiers Dihydroartemisinin Transferrin Adducts Enhance TRAIL Induced Apoptosis in Triple Negative Breast Cancer in a P53 Independent and ROS Dependent Manner MDA MB 468 Xenograft Model Altogen Labs RSL3 induces ferroptosis by activating the NF B signalling pathway to enhance the chemosensitivity of triple negative breast cancer cells to paclitaxel Scientific Reports
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



